cognitive decline

Seniors at Lions Befrienders playing the AMI app on their tablets
By  Adam Ang 05:32 am October 11, 2023
A new mobile app developed in Singapore holds promise to prevent the progression of dementia by helping improve the multilingual thinking of senior folks.  HOW IT WORKS A team of app developers at the Singapore University of Technology and Design (SUTD) has built what could be the world's first multilingual app for dementia prevention, Ami (an acronym for Advancing Mental Invigoration).  Its...
Healthcare provider and senior citizen on a tablet
By  Jessica Hagen 01:19 pm November 2, 2022
Neurotrack, a company developing digital cognitive health tools, launched a three-minute digital assessment tool to screen for cognitive impairment during wellness appointments. The digital exam is designed to help identify cognitive impairment and decline, an early indicator of neurodegenerative conditions like Alzheimer's. The tool can be used during a primary care annual wellness visit or...
An older man and doctor looking at results on a tablet.
By  Emily Olsen 01:27 pm November 3, 2021
BrainCheck, the company behind a platform that helps assess cognitive impairment, has raised $10 million in Series B funding. The round was led by Next Coast Ventures and S3 Ventures, with participation from Nueterra Capital, Tensility Ventures and True Wealth Ventures. BrainCheck also secured strategic investment from UPMC Enterprises and SelectQuote. BrainCheck said the latest round of funding...
iPhones displaying Apple's latest health updates
By  Emily Olsen 01:34 pm September 20, 2021
Apple update. iPhone users will have access to new health features in iOS 15, released today, MobiHealthNews has learned. The update includes a sharing feature within the Health app that allows users to share their data with their loved ones, a walking-steadiness biomarker that provides insights into fall risk and a trends feature that can highlight any changes in their collected health data. In...
A nerve cell affected by Alzheimer's disease
By  Dave Muoio 02:25 pm March 10, 2021
Yesterday Cognito Therapeutics, a startup using visual and auditory stimulation to treat neurodegenerative disorders, announced Phase 2 trial results suggesting its gamma frequency neuromodulation therapy slowed declines in memory and cognition among mild-to-moderate Alzheimer's disease patients. The OVERTURE study, a multi-center, randomized controlled trial, enrolled 76 such patients aged 50...
By  Dave Muoio 03:08 pm August 8, 2019
Sensors from consumer-grade devices like iPhones, Apple Watches, iPads and Beddit sleep monitors capture enough data to spot mild cognitive impairment or Alzheimer’s disease dementia, according to a new feasibility study conducted jointly by Apple, Eli Lilly and Company and Evidation Health researchers that was presented today at a research conference held in Anchorage, Alaska. “Over the past few...